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EXECUTIVE SUMMARY. For the American Association of Colleges of Pharmacy (AACP)
strategic engagement is critical to the success of colleges and schools of pharmacy in expanding
pharmacy and public health practice, meeting programmatic needs, and fulfilling institutional
missions. The 2019-2020 Strategic Engagement Committee was charged with exploring the col-
laborative relationships colleges and schools have within their state to advance pharmacy practice.
More specifically, this committee was tasked to examine those relationships with current state
pharmacy and medical associations. This report seeks to provide insights from this work and
share recommendations to assist AACP in facilitating practice transformation. To uncover current
schools’ relationships with state and medical associations, the committee utilized AACP’s ability
in convening members to conduct focus groups at INsight 2020 and one-on-one interviews with key
faculty members. Overall, partnerships with state pharmacy associations are successful or growing,
whereas there is still work to be done in developing relationships and collaborating with medical
and health care societies. We found that there are several schools with “best practices” related to
state association collaborations and look to highlight exemplar practices in this report as they are
critical towards practice transformations.
Recommendations and Suggestions
Based upon the work of the 2019-2020 Strategic
Engagement Committee, the following recommendations
are provided to AACP and schools and colleges of phar-
macy, along with one suggestion to colleges and schools
of pharmacy:
1. AACP should create an internal campaign to in-
crease awareness among members of the impor-
tance of enhancing advocacy efforts at the national,
state and local levels while highlighting those
schools with successful partnerships.
2. AACP should convene high level stakeholders
(eg, CEO deans) to promulgate support for ded-
icated advocacy resources within colleges/
schools of pharmacy.
3. AACP should create programming to enhance the
skills of faculty and administrators related to cre-
ating systems of advocacy and collaboration
between colleges/schools of pharmacy and health
profession societies to advance practice.
4. AACP should work with schools to build relation-
ships with national pharmacy and health profession
societies that promote collaboration for practice
advancement and transformation.
5. AACPshould engage furtherwith the state associations
togain their perspectivesonsuccessfulpartnershipsand
how schools could work together with them.
6. AACP should create recognition for effective ad-
vocacy efforts through a potential award given
yearly to a school.
Suggestion for Schools and Colleges of Pharmacy:
1. Schools and colleges of pharmacy should dedicate
resources to support the school/college’s engage-
ment in practice advancement workwith pharmacy
and health profession societies at a state level.
































































AACP’s 2004-05 Argus Commission defined com-
munity engagement as “the application of institutional
resources to address and solve challenges facing
communities through collaboration with these com-
munities.”1 More recently, AACP has streamlined its
processes and aligned its resources to broaden its focus
from advocacy to strategic engagement and position
itself to prioritize, initiate, and maintain initiatives, as
needed. The 2018-2019 Strategic Engagement Stand-
ing Committee Charges include the exploration of
faculty leadership and development as they relate to
active participation in strategic engagement-related
activities, challenges and barriers to engagement in
such activities, and strategic engagement successes
and non-traditional opportunities. Previous AACP
Standing Committees tackled multiple important and
high priority issues engaging internal stakeholders and
external partners. From these discussions, knowledge,
guidance, and specific recommendations related to
engagement were shared with The Academy. This
year’s committee will look to examine these rela-
tionships with state associations and medical societies
through interviews and focus groups of faculty mem-
bers and key stakeholders.
INTRODUCTION AND COMMITTEE
CHARGES
According to the Bylaws of the American Associa-
tions of Colleges of Pharmacy (AACP), the Strategic En-
gagement Committee “will advise the Board of Directors
on the formation of positions on matters of public policy
and strategies to advance those positions to the public and
private sectors on behalf of academic pharmacy.”
President Sorensen presented the 2019-2020 com-
mittee with the following charges:
1. Evaluate the nature of collaborative relationships
between schools of pharmacy and state pharmacy
associations with respect to supporting advance-
ment of pharmacy practice. Identify promising
practices that should be disseminated across the
Academy.
2. Identify ways in which the profession (profes-
sional organizations and schools), within individual
states, is partnering with medical societies to
identify common priorities and opportunities for
collaboration.
3. Define strategies and draft an action plan for
AACP’s role in catalyzing school efforts to partner
with pharmacy and medical societies for the pur-
pose of advancing collaborative practice.
Process
Each year, AACP members are provided an oppor-
tunity to respond to an open call to express their interest in
serving on various committees. The incoming AACP
President, along with AACP staff, also identify members
with interest and experience that aligns with committee
charges. AACPmembers are then assigned to committees
based on this expertise in a manner to ensure represen-
tation from different schools and colleges of pharmacy.
Members identified for service on the committee are then
contacted directly to verify their interest and availability.
Committee members were notified of their official
selection prior to the AACP Annual Meeting in 2019,
which provided some opportunity for committee mem-
bers to meet in person and conduct brief introductions.
Members met virtually in early Fall 2019 to review
charges and begin thinking of ways in which committee
charges could be achieved. An in-person meeting was
conducted in Washington, DC in January 2020 with
remainingmeetings conducted virtually during the Spring
of 2020.
The committee determined that it would be neces-
sary to collect data from member colleges and schools in
order to evaluate the nature of the relationships which
exist between member institutions and state pharmacy
associations, as well as medical societies. The committee
believed that exemplar success stories could be gathered
as a part of this data collection and collated for dissemi-
nation to the Academy so that key successful tools and
strategiesmight be repeated by others around the country.
It was determined that focus groups would be utilized in
order to collect needed information with follow-up indi-
vidual interviews being used as needed to complete data
collection.2
In January 2020, the committee came together for an
in-person meeting over the span of two days. During this
time, the following definition for collaborative practice
transformation activities was agreed upon to guide the
planned focus group discussions. Collaborative practice
transformation activities were defined as:
d Joint advocacy efforts between colleges/schools and
pharmacy/medical/health professional/patient ad-
vocacy organizations for practice innovation in-
cluding payment for pharmacy services;
d Partnerships between colleges/schools of pharmacy
and medical/health professional/patient advocacy
organizations to support and/or provide innovative,
interprofessional practice initiatives; and
d Partnerships between colleges/schools of pharmacy
and other entities (state pharmacy associations, state
medical associations, patient advocacy groups, etc.)
to scale models for innovative, interprofessional































































practice through provision of education/training for
practicing pharmacists to provide these advanced
services.
An interview guide was developed to facilitate the
focus groups and individual interviews. This guide, based
on an implementation framework (Appendix 1) included
questions meant to generate responses to provide infor-
mation around the themes of effective innovation, the role
of relationships, implementation contexts or barriers, and
key outcomes achieved. The committee determined that
live focus groups would be held in conjunction with the
AACP Insight 2020 interim meeting in Puerto Rico in
February. Participants in the focus groups were identified
from the lists of registered attendees. Discussion among
committee members regarding attendees and Colleges/
Schools known for ongoing advocacy work generated an
invitation list of participants.
Two focus groups were held on February 9th and 10th
as part of the AACP Insight meeting and as a joint effort
with the AACP Professional Affairs Committee. At the
conclusion of each session, attendees were asked to pro-
vide the names of additional colleagues at their institu-
tions who could provide information upon follow-up
related to advocacy efforts. Additional planned focus
groups at the 2020 National Alliance of State Pharmacy
Associations (NASPA) meeting held in conjunction with
the American Pharmacists Association annual meeting in
March 2020 could not be held as the meetings were
canceled due to COVID-19.
Therefore, additional individual interviews were
scheduled inMarch and April to complete data collection
using contacts generated from the focus groups. Addi-
tional committee input generated other key informants at
colleges/schools of pharmacy who were not already rep-
resented. The committee contacted these key informants
for one-on-one virtual interviews. Data from all focus
groups and individual interviews were collated and form
the basis for the committee’s recommendations. Com-
mittee members completed the final report in May 2020.
AACP is uniquely positioned to convene members,
faculty, administrators, deans and relevant stakeholders
through their yearly Interim and Annual meetings. After
conducting focus groups and interviews, we see that it
would be beneficial to host special sessions, at Interim or
Annual meeting, focusing on the importance of devoting
resources (ie, dean-level position, FTE time for faculty,
recognition in RPT, etc.) to advocacy and practice ad-
vancement efforts with potential tools and resources to
assist in implementation. Creating an internal awareness
amongst members, would be a strong catalyst in devel-
oping and strengthening partnerships that aid in advocacy
and practice transformation.
Related to sessions at AACP meetings, there is po-
tential to create systems of advocacy and collaboration
between schools and colleges of pharmacy and health
profession societies to advance practice through a special
session(s). Furthermore, after development and discus-
sionswith relevant stakeholders, a training or certification
program to enhance skill development would be very
beneficial to school administrators looking to expand
their partnerships.
Focus Group and Interview Findings
Although there was variation in practice across
schools/colleges, there were some common elements and
consistent themes that linked to success in advancing
practice transformation through partnership with state
pharmacy associations. Most schools reported either a
long-term positive relationship with their state pharmacy
association or that this relationship is growing. There
seems to be an increasing awareness of the importance of
the state associations, with some schools now paying for
faculty membership in associations. Importantly, suc-
cessful partnerships included colleges/schools whose
faculty members are serving as board members or in key
leadership roles for their state associations.
These relationships appear to pay dividends, as
progressive legislative successes seem to be tied to a
strong relationship between state association and faculty
and students within colleges/schools. State associations
have extensive policy know-how, timely awareness of
legislative activity, and are able to hire lobbyists, while
faculty and students provide professional practice expe-
rience and can testify to the value of pharmacy practice
when making their case to legislators. Integration of
legislative days and stakeholder engagement into curric-
ular activities helps sustain these school-association re-
lationships and enables faculty and student leadership.
In order to stimulate interest and garner support for
schools to foster collaboration with state associations, a
campaign led by AACP should be created. We envision
the campaign to have two components. In our investiga-
tion, we heard from some who had begun working with
state associations but were really interested in growing
their partnership and wanted more guidance on what
others were doing. Therefore, we envision one aspect of
the campaign inward facing. AACPwould help showcase
how schools can begin to engage or expand relationships
with their state associations through examples of suc-
cessful partnerships along with strategies for curricular
integration. The second component of the campaign
would be outward facing using video vignettes. In these
videos, AACP would showcase some of the great suc-
cesses schools have had in working with their state































































associations and the outcomes that have resulted in im-
proving practice transformation. This campaign would
serve as guidance highlighting the importance of advo-
cacy efforts at the national, state and local levels.
Recommendation 1: AACP should create an inter-
nal campaign to increase awareness among members of
the importance of enhancing advocacy efforts at the na-
tional, state and local levels while highlighting those
schools with successful partnerships.
A common theme we noticed within the successes
that were expressed by members in our one-on-one in-
terviews was a dedicated group of faculty and/or depart-
ment-level programs. There were “Centers for Practice
Improvement” where several faculty within the “Center”
had clear roles to advance and advocate for state-level
policies to improve pharmacy practices. This is important
as it provides a common platform of support from each
college and school of pharmacy.
We also saw some “state-wide collaboratives”where
membership in the “collaborative” was often a combi-
nation of several stakeholders. It comprised key faculty,
who represented most colleges/schools in the state, deans
from colleges/schools of pharmacy, executive members
of the state pharmacy association(s), and other key
stakeholders such as pharmacy executives from both
hospital systems and community-based organizations.
The “collaborative” would meet 2-4 times per year to
discuss advocacy and policy strategies.
Creating an environment that empowers faculty to
work in these collaborative settings allows them to then
empower students to be their own advocates as they learn
from relevant stakeholders to see the current needs of the
profession in settings students will soon enter. AACP is
uniquely positioned to create these avenues to enhance
the skills faculty obtain to learn how to build these col-
laborative settings. These hubs built around collaboration
are critical in developing true practice transformation.
Recommendation 2: AACP should convene high
level stakeholders (eg, CEO deans) to champion for
dedicated advocacy resources within colleges/schools of
pharmacy.
Recommendation 3: AACP should create pro-
gramming to enhance the skills of faculty and adminis-
trators related to creating systems of advocacy and
collaboration between colleges/schools of pharmacy and
health profession societies to advance practice.
Suggestion 1: Schools and colleges of pharmacy
should dedicate resources to support the school/college’s
engagement in practice advancement work with phar-
macy and health profession societies at a state level.
Experience with medical associations was less
common, with only one school reporting a substantial
relationship with the state medical association. Much
more common was collaboration with individual medical
practitioners, and schools did report relationships im-
proved when individual medical practitioners collabo-
rated with pharmacists. Garnering support from
individual physicians such as deans of medical schools
and chief clinical officers of hospitals or community
groups for policies rather than direct endorsement from
societies and associations was a good strategy. If there
was another key success, it was more related to other key
stakeholders such as statewide large employers, hospital
groups, or insurers such as Medicaid.
Through our focus groups and interviews, it seemed
that the little successes that did exist withmedical societies
were mostly defined by ensuring that the medical profes-
sional groups were “not against” them on advocacy efforts.
If the medical professionals were neutral about a specific
policy or legislation, it was seen as a win. Overall, the re-
lationship with medical societies was negative to non-ex-
istent. There is generally lots of room for improvement in
medical society relationships, but there was little mention
overall in interviews as being a priority. There is significant
room for improvement in relationships with medical as-
sociations, and a need for the pharmacy profession to de-
velop a positive definition of success in these relationships.
However, it is important to note that due to COVID-19, the
committee did not get a chance to really delve into these
relationships with much depth.
Recommendation 4: AACP should work with
schools to build relationships with national pharmacy and
health profession societies that promote collaboration for
practice advancement and transformation.
Recommendation 5: AACP should engage further
with the state associations to gain their perspectives on
successful partnerships and how schools could work to-
gether with them.
With some of the continuous collaborative efforts
and successes schools have had, the committee believes it
would be beneficial to develop a recognition tool, such as
an annual award. We believe an award would not only
continue the great work schools and colleges of phar-
macies have done in building up successful partnerships,
but also, the award could serve as a motivating tool for
schools to continue or begin working with their state
associations.
Recommendation 6: AACP should create recogni-
tion for effective advocacy efforts through a potential
award given yearly to a school.
Success Stories and Best Practices
Through our focus groups and interviews, we were
able to see some good successful initiatives and collaborative































































practices. There were some common practices that are
done at multiple schools, such as legislative days, intern-
ship opportunities and conference meetings preparing
students to take part in advocacy.
We saw schools implementing legislative days into
their curriculum, where students would learn the advo-
cacy process through the help of faculty and state asso-
ciations. The structure focused on providing students the
ability to have at least one experience in understanding the
legislative process. Students would hear from the state
associations on bills that could impact their practice in the
future, and learn from legislators and lobbyists about the
current culture and major issues that might need to be
addressed outside of pharmacy. Students were either en-
couraged or guided on how to contact their legislators
ahead of time to request a meeting, followed by a full
legislative day at the state capitol talking to legislators and
their staffs.
Another unique design we sawwas the opportunity
for students to take part in legislative internships.
During the internship, they would work with a member
of their alumni, not necessarily a pharmacist, whose job
was tied to public policy or a state agency. This would
allow students to spend time at the capitol and research
issues. We saw this used as a professional elective
typically for P3 students as they are in the area the entire
semester. The internship could count toward Personal
Professional Development advocacy. This experience
often led these students to pursue policy opportunities
in the future.
The committee plans to compile a supplemental
document detailing the states and schools we were able to
hear from to share some of their practices and work. We
are looking to coordinate with AACP on the best way to
disseminate that information as supplementalmaterial for
this report.
It is also important to note, although these are some
of the best practices shared in our discussionswith faculty
members, we must add the disclaimer that each state
varies. The legislative landscape combined with the in-
frastructure of the state associations themselves are key
attributes that lead to the type of collaborative practices
that are created.
CONCLUSION
Based on the findings of the focus groups and in-
terviews the committee developed a series of recom-
mendations for specific strategies and tactics which the
committee believes could be achieved. Through both
assistance and guidance from AACP, and with collabo-
ration among members, we can reach the goal of practice
transformation and the bold aim of reaching widespread
collaboration with primary care professionals. The six
recommendations put forth by the committee look to
highlight some of the ways schools and colleges of
pharmacy can engage in successful collaborations with
their state pharmacy associations.
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Appendix 1. Interview Guide—Use of CFIR Framework (see bottom of guide for table of constructs)
Introduction (and use as part of invitation email)
Goal:We are interested in learning about your experience in collaborationwith policy and advocacywork. In particular, our goal is to
learn about “best practices” in promoting pharmacy practice change through collaboration with your state pharmacist or other health
care associations.
Collaborative Practice Transformation Activities Definition - For the purpose of this discussion, collaborative practice transforma-
tion activities are defined as:
Joint advocacy efforts between colleges/schools and pharmacy/medical/health professional/patient advocacy organizations for
practice innovation including payment for pharmacy services;
Partnerships between colleges/schools of pharmacy/medical/health professional/patient advocacy organizations to support and/
or provide innovative, interprofessional practice initiatives;
Partnerships between colleges/schools of pharmacy and other entities (state pharmacy associations, state medical associations,
patient advocacy groups, etc.) to scale models for innovative, interprofessional practice through provision of education/training for
practicing pharmacists to provide these advanced services.
Effective Innovation
Please tell us about a time when you were successful with promoting/advocating for practice change in your state.
What was the background and rationale for the change?
Why was this change necessary?































































What created the urgency for this change?
What scientific evidence supported the change?
What were the key strategies and actions that led to this success? In what way were pharmacy and other health professions asso-
ciations included in this effort?
Role of Relationships
What is the nature of the relationship between your college/school of pharmacy and the state pharmacy associations for the ad-
vancement of practice in your state?
How did those relationships come about?
How were they fostered in the short term?
How were they fostered in the long term?
What strategies did you employ to foster or leverage those relationships?
What is the nature of the relationship between your college/school of pharmacy and the state associations for other health professions
for the advancement of practice in your state?
How did those relationships come about?
How were they fostered in the short term?
How were they fostered in the long term?
What strategies did you employ to foster or leverage those relationships?
What types of relationships did you have with other organizations such as patient advocacy organizations and public health to
advance pharmacy practice in your state?
How did those relationships come about?
How were they fostered in the short term?
How were they fostered in the long term?
What strategies did you employ to foster or leverage those relationships?
Implementation Contexts or Barriers
What principles or activities led to your success?
Can you describe the structure and allocation of resources for advocacy work in the college/school of pharmacy?
What was the role of your college/school of pharmacy in this change?
Who specifically contributed in a meaningful way?
How did they contribute?
What factors or circumstances were a barrier to your success?
Key Outcomes
What were the key outcomes that occurred?
What other unintended outcomes have occurred from this effort?
Follow Up
Are there other people at your school we can follow up with regarding partnerships with your state association, medical association,
or other groups with whom you have partnered for advocacy efforts?
We would be interested in having some of these success stories shared through a brief video vignette. Would you be willing to share
your story through this media?

































































Intervention Characteristics Intervention Source





Design Quality and Packaging
Cost
Outer Setting Patient Needs and Resources
Cosmopolitanism
Peer Pressure
External Policy and Incentives





Characteristics of Individuals Knowledge and Beliefs About the Intervention
Self-Efficacy
Individual Stage of Change
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